Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease
- 1UK Dementia Research Institute at the University of Edinburgh
Abstract
Cellular mechanisms in early Alzheimers disease (AD) remain poorly understood despite generation of extensive observational multiomic data. Weighted integration across diverse datasets can prioritise convergent mechanisms and targets. We conducted a systematic review to identify datasets profiling cell-type-specific changes in early AD. We integrated multiomic findings using Meta-Analysis by Information Content (MAIC), a computational method which combines genomic data from diverse experimental sources. Electron transport chain dysfunction in mitochondria emerged as a shared pathway in neurons, microglia, and astrocytes, and Wnt signalling was a prominent astrocyte-specific signature. Pathological neuro-glial signalling mechanisms included APP-CD74, APOE-SORL1, and WNT-FZD/LRP6. Integration with pharmacological data identified therapeutics already under investigation in AD, such as guanfacine, and candidates not previously prioritised, such as eltrombopag and encorafenib. We present a systematic analysis of cell-type-specific changes in early AD to prioritise pathways for investigation and therapeutics for repurposing.
Related
- Cross‐cohort NULISAseq identifies tau‐anchored CSF and plasma‐specific signatures across the amyloid‐positive Alzheimer's disease
- Genomic Profiling of Estrogen-Related Receptor Identifies Adult Adipocyte-Specific Targets in Drosophila
- Genomic profiling of estrogen-related receptor identifies adult adipocyte-specific targets in Drosophila
- Phase-specific neuromechanical signatures of 40-m sprint performance: an integrated two-dimensional kinematic and surface electromyographic profiling study
- Integrated multi-omics identifies distinct immune signatures with diagnostic and therapeutic implications in immune checkpoint inhibitor-induced myocarditis
BibTeX
@misc{steinruecke2026integrated,
title = {{Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease}},
author = {M. Steinruecke and J. K. Baillie and Z. Jiwaji},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.21.26362150},
url = {https://www.medrxiv.org/content/10.64898/2026.09.21.26362150v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease
AU - M. Steinruecke
AU - J. K. Baillie
AU - Z. Jiwaji
PY - 2026
DA - 2026/09/21
PB - medRxiv
DO - 10.64898/2026.09.21.26362150
UR - https://www.medrxiv.org/content/10.64898/2026.09.21.26362150v1
AB - Cellular mechanisms in early Alzheimers disease (AD) remain poorly understood despite generation of extensive observational multiomic data. Weighted integration across diverse datasets can prioritise convergent mechanisms and targets. We conducted a systematic review to identify datasets profiling cell-type-specific changes in early AD. We integrated multiomic findings using Meta-Analysis by Information Content (MAIC), a computational method which combines genomic data from diverse experimental sources. Electron transport chain dysfunction in mitochondria emerged as a shared pathway in neurons, microglia, and astrocytes, and Wnt signalling was a prominent astrocyte-specific signature. Pathological neuro-glial signalling mechanisms included APP-CD74, APOE-SORL1, and WNT-FZD/LRP6. Integration with pharmacological data identified therapeutics already under investigation in AD, such as guanfacine, and candidates not previously prioritised, such as eltrombopag and encorafenib. We present a systematic analysis of cell-type-specific changes in early AD to prioritise pathways for investigation and therapeutics for repurposing.
ER -